Assignee
ABON PHARMACEUTICALS LLC
US·6 granted patents·3 pending applications·6 citations·filing 2013–2023
Top patents by PatentIndex Score
9 records- 0182US9352047B2Oral transmucosal drug delivery systemABON PHARMACEUTICALS LLC·Filed 2013·Granted May 31, 2016·5 cites·20 claims
- 0271US9795616B2Oral transmucosal drug delivery systemABON PHARMACEUTICALS LLC·Filed 2016·Granted Oct 24, 2017·1 cites·19 claims
- 0369US11801233B2Oral eliglustat transmucosal delivery systemABON PHARMACEUTICALS LLC·Filed 2022·Granted Oct 31, 2023·0 cites·20 claims
- 0469US2023248720A1Long Acting Injectable FormulationsABON PHARMACEUTICALS LLC·Filed 2023·Application pending·0 cites
- 0563US11413271B2Oral eliglustat transmucosal delivery systemABON PHARMACEUTICALS LLC·Filed 2019·Granted Aug 16, 2022·0 cites·20 claims
- 0662US10821118B2Oral transmucosal drug delivery systemABON PHARMACEUTICALS LLC·Filed 2017·Granted Nov 3, 2020·0 cites·21 claims
- 0756US11596628B2Long acting injectable formulationsABON PHARMACEUTICALS LLC·Filed 2016·Granted Mar 7, 2023·0 cites·18 claims
- 0848US2021379090A1Remdesivir oral delivery systemABON PHARMACEUTICALS LLC·Filed 2021·Application pending·0 cites
- 0942US2017196802A1Long Acting Injectable FormulationsABON PHARMACEUTICALS LLC·Filed 2016·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ABON PHARMACEUTICALS LLC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →